Sarah Bauder is the senior editor at Lab Manager. She possesses a diverse background spanning editorial, digital marketing and film and television production. She brings over 15 years of experience
The modern life sciences laboratory is undergoing a quiet but profound transformation. The pipette-driven bench that defined generations of scientific work is giving way to connected, self-directing systems that design experiments, execute them, and learn from the results. Yet the path forward is not about handing the lab over to algorithms, but about sequencing change intelligently and preserving the human judgment that keeps science credible. AI-driven lab automation works best when artificial intelligence augments skilled scientists rather than displacing them. That was the central message from Tina Yauger, principal consultant and technical lead at Clarkson Consulting, during her session at the 2026 AI in Lab Automation Digital Summit. With more than 16 years of experience in laboratory information management systems (LIMS) and lab informatics across pharmaceutical, cell and gene therapy, biologics, and food and beverage settings, Yauger offered lab leaders a grounded roadmap for modernization—one that treats AI as an amplifier of human capability, not a replacement.
What separates a traditional lab from an automated
Tina Yauger, principal LIMS consultant at Clarkston Consulting.
one?
To understand where AI fits, it helps to see what it displaces. The traditional laboratory, as Yauger described it, leans heavily on scientists and technicians to manually design experiments, prepare samples, operate instruments, collect data, and interpret results. Work moves sequentially—one experiment finishes, its findings are reviewed, and only then does the next take shape. Meanwhile, data lives in siloed systems and is examined after the fact.
As Yauger noted, this legacy model carries inherent friction, making operations "more susceptible to bottlenecks, human error, and limited human knowledge." Every manual handoff invites transcription mistakes, consuming time scientists could otherwise spend on higher-value innovation.
Automation begins to dissolve those constraints. Yauger defined it simply as "using technology to execute tasks with little to no human involvement," automation exists on a continuum—ranging from isolated liquid handling to a fully autonomous "lights-out" laboratory. Crucially, labs do not need to reach the far end of that spectrum immediately; automation can be adopted incrementally.
Where should automation start in the lab?
Yauger walked through the common entry points, and her sequencing matters for leaders planning investments. Liquid handling robots that measure, mix, and dispense with precision are a familiar starting place, and robotic sample storage and retrieval systems can process up to 1,500 tubes per hour unattended in high-volume biobanking and clinical labs.
But the most common—and most strategic—first step is instrument interfacing. Linking an instrument directly to a LIMS transfers data seamlessly, speeds capture, and eliminates transcription errors. Yauger was direct about why this delivers such a strong return: manual entry of instrument values is not only error-prone but "a redundant and time-consuming task for lab staff, making instrument integration a large all-around win." Once basic interfacing is established, system integration can expand the LIMS from an isolated database into a connected ecosystem—linking directly to Enterprise Resource Planning (ERP) systems like SAP or Oracle to manage inspection lots and final dispositions automatically.
Lab Quality Management Certificate
The Lab Quality Management certificate is more than training—it’s a professional advantage.
Gain critical skills and IACET-approved CEUs that make a measurable difference.
Critically, Yauger urged leaders to assess infrastructure before assuming these connections will be simple. Firewalls, firewalls, segregated networks, and strict cybersecurity policies can complicate integration. As laboratory informatics move increasingly to web-based platforms, security policies must evolve to protect networks against emerging operational risks.
The most common laboratory automation entry points, roughly in order of adoption, include:
Liquid handling: Robots that precisely measure, mix, and dispense liquids for pipetting and serial dilutions.
Robotic sample storage and retrieval: Automated systems that store, track, and retrieve samples—processing up to 1,500 tubes per hour in high-volume biobanking and clinical labs.
Sample preparation: Automated centrifugation, mixing, and other repetitive prep tasks that can extend to lights-out operation with analytical instruments.
Instrument interfacing: Direct instrument-to-LIMS connections that speed data capture and eliminate transcription errors—often the best starting point.
System integration: Connecting the LIMS to ERP, MES, or ELN systems to build a unified laboratory ecosystem.
Advanced analytics and AI: Statistical modeling, machine learning, and predictive capabilities layered onto automated data.
What does automation actually deliver?
The benefits Yauger outlined map directly to the metrics lab leaders are measured on—throughput, compliance, cost, and ultimately return on investment (ROI). Automated systems execute the same protocol uniformly, reducing deviations and outliers while accelerating turnaround. They generate detailed audit trails—sample ID, user ID, and timestamp—that make compliance with standards such as 21 CFR Part 11 and ISO 17025 far easier to demonstrate, helping satisfy the regulatory expectations of the FDA, EPA, and CLIA.
There is a human dividend, too. By removing repetitive, physically demanding, and sometimes hazardous tasks, automation lowers burnout risk and lets scientists concentrate on analysis, research, and experimental design. Systems that run overnight and over weekends expand capacity without round-the-clock staffing, while optimized reagent use and lower labor costs strengthen the bottom line.
Interested in lab tools and techniques?
Register for a FREE Lab Manager account to subscribe to our Lab Tools & Techniques Newsletter.
The core benefits of laboratory automation include:
Consistency and precision: Uniform protocol execution that reduces deviations, outliers, and fatigue-driven error.
Faster turnaround: Higher sample throughput and quicker results.
Easier compliance: Built-in audit trails and data traceability that support 21 CFR Part 11, ISO 17025, and FDA, EPA, and CLIA requirements.
Better data integrity: Direct instrument-to-LIMS capture that reduces lost or incomplete data.
Improved staff wellbeing: Less repetitive and hazardous work, lowering burnout and raising satisfaction.
Expanded capacity: Overnight and weekend operation without additional staffing.
Lower costs and greater scalability: Reduced labor and reagent waste, plus infrastructure that adapts to new technologies.
How should labs think about adding AI?
Once tasks are automated, Yauger argued, the lab is ready to look for places where AI can make workflows smarter. Her guiding principle is one every lab leader should internalize: like automation, AI "should not be used to replace, but only to augment." She reinforced the point with a line she attributed to Forbes: "AI will not replace you, but a human using AI will."
That framing is not merely philosophical—it is increasingly a compliance imperative. Yauger highlighted the FDA's guiding principles on good AI practice, singling out the human-centric principle as a reminder that human oversight remains critical. She then pointed to a concrete warning shot: in April 2026, the FDA issued its first enforcement action targeting a drug manufacturer's inappropriate use of artificial intelligence, citing the company for over-relying on AI and failing to maintain human-in-the-loop oversight for compliance documents, specifications, and manufacturing records.
The takeaways she drew from that case belong on every quality leader's wall. Companies cannot use AI to generate required GMP procedures or records without thorough review and clearance by an authorized human. Ignorance caused by an AI error—such as a system failing to flag a validation requirement—does not excuse a company from its legal controls. As Yauger stated, "responsibility for regulatory compliance cannot be delegated to technology." The quality unit retains ultimate authority over anything affecting a product's identity, strength, or purity.
Where does AI add the most value?
With those guardrails in place, Yauger mapped the highest-impact applications of AI-driven lab automation. In experimental design, AI can augment classical design of experiments (DOE), predicting outcomes across factor combinations and recommending the runs most likely to yield results—often cutting the number of experiments needed to reach an optimum. Her recommended posture is telling: the best practice is "DOE plus AI, not DOE versus AI," where a sound classical design sets the foundation, AI guides subsequent runs, and human experts validate every recommendation. A formulation scientist testing temperature, pH, and concentration, for instance, might face hundreds of combinations; AI can pinpoint the experiments expected to maximize the outcome while minimizing runs. Paired with closed-loop or "self-driving" experimentation—where each result updates the predictive model and shapes the next procedure—this compresses discovery timelines while supporting quality-by-design initiatives.
Predictive modeling extends the same logic across operations. AI can flag anomalies such as instrument drift before results are finalized, and it can monitor equipment usage to predict failures and trigger maintenance before unplanned downtime occurs—predictive maintenance that often delivers some of the fastest, most measurable ROI, since a single avoided failure protects both turnaround times and costly samples. It can also model seasonal variability (Yauger's example of a dairy company navigating peak milk season is a reminder that these tools serve operational planning, not just the bench) or simulate temperature and humidity conditions to assess shelf life. The effect, she summarized, is a shift "from a reaction to a proactive approach."
Computer vision adds another layer, using cameras and AI models to detect, classify and count microscopic samples faster than a human can, monitor equipment for wear, watch dynamic tests for signs of trouble such as bubbling or color change, and even enforce safety protocols. In a pathology setting, computer vision tools can be trained to analyze biopsy tissue and blood samples for abnormalities, supporting faster and more precise diagnostics. Taken together, these capabilities can drive the fully autonomous "lights-out lab," where cognitive agents interpret results and choose the next step, digital twins simulate experiments before they are physically run, and the lab, in Yauger's words, "continuously learns and improves with each experiment."
What are the risks lab leaders cannot ignore?
Yauger was candid about how AI adoption introduces specific technical and operational hazards that require active risk management: some severe, which is precisely why human expertise stays central. The key risks lab leaders should plan for include:
Costly upgrades: Legacy equipment may need replacement to support AI.
The black box problem: Opaque decision-making that undermines validation.
Hallucinations and bad data: Incorrect setups or misinterpreted results that risk dangerous reactions or invalid samples.
Model degradation: Quality decline when AI output is repeatedly fed back into the same model.
Over-reliance: Erosion of scientists' own anomaly-spotting and judgment.
Complex validation: Pattern-based models that are harder to validate than rule-based systems.
To mitigate these risks, Yauger suggested that organizations should establish regular revalidation schedules—comparing AI-generated results against human-driven parallel processes—maintain strict regulatory governance, and continuously train staff to recognize model limitations.
The five-year outlook
Yauger closed with a picture of the laboratory roughly five years in the future: relying on central AI systems to orchestrate workflows, manage robotic sample preparation, and analyze data in real time through closed-loop feedback. In that environment, the scientist's role transitions from manually executing routine work to "digitally managing the innovation."
For lab leaders, the strategic sequence embedded in Yauger's presentation is the real deliverable. Assess your infrastructure. Automate deliberately, starting with instrument integration. Layer AI onto stable, automated processes rather than fragile manual ones. And at every stage, treat human oversight not as a constraint on progress but as the thing that makes progress trustworthy. The labs that thrive will not be the ones that adopt AI fastest, but the ones that adopt it wisely.
Add Lab Manager as a preferred Google source to see more of our trusted coverage.
Frequently Asked Questions (FAQs)
What is AI-driven lab automation?
AI-driven lab automation combines robotic and software automation with artificial intelligence to design experiments, execute them, and learn from the results with minimal human intervention. It works best when AI augments skilled scientists rather than replacing them, keeping human oversight at the center of the workflow.
Where should a lab start with automation?
The most common and strategic starting point is instrument interfacing—linking instruments directly to a LIMS to speed data capture and eliminate transcription errors. From there, labs can expand into system integration, connecting the LIMS to ERP or other systems to build a unified laboratory ecosystem.
What are the main benefits of AI and automation in the lab?
Automation delivers consistent protocol execution, faster turnaround, easier regulatory compliance, and lower costs, while AI adds predictive modeling, experiment optimization, and predictive maintenance. Together they improve throughput and ROI while freeing scientists to focus on higher-value analysis and research.
What are the biggest risks of using AI in the laboratory?
Key risks include the "black box" problem, AI hallucinations or bad training data, model degradation over time, and scientists becoming over-reliant on the tools. These can be mitigated through routine revalidation against human-driven results, strict data governance, and ongoing staff training on the tools' limits.
Sarah Bauder is the senior editor at Lab Manager. She possesses a diverse background spanning editorial, digital marketing and film and television production. She brings over 15 years of experience in editorial writing, B2C and B2B content creation. A student of history, she graduated from York University in Toronto, Ontario, Canada. She can be reached at sbauder@labmanger.com.
